Specialty

Pharmacoepidemiology, outcomes research, health economics, biostatistics

Works

Researchi reports

1 Konomura, K., Hoshino, E., Sakai, K., Fukuda, T., Tajima, G. Development of a Model for Quantitative Assessment of Newborn Screening in Japan Using the Analytic Hierarchy Process. Int. J. Neonatal Screen. 2023, 9, 39. https://doi.org/10.3390/ijns9030039

2 Izumi, S., Hagiwara, Y., Matsuyama, Y. et al. Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L. Health Qual Life Outcomes 21, 3 (2023). https://doi.org/10.1186/s12955-022-02085-8

3 Morii Y, Abiko K, Ishikawa T, et al. Regional disparity in the provision of rehabilitation services using the open data from the Japanese national claims database: an ecological study BMJ Open 2023;13:e071670. doi: 10.1136/bmjopen-2023-071670

4 Iketani R, Konomura K. Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database. BMC Health Serv Res. 2022; 21;22(1):682.

5 Eri Hoshino, Kensuke Moriwaki, Kosuke Morimoto, Kotomi Sakai, Nobuyuki Shimohata, Keiko Konomura, Kevin Y. Urayama, Mitsuyoshi Suzuki, Kojiro Shimozuma. Cost-effectiveness analysis of universal screening for biliary atresia in Japan. The Journal of Pediatrics. 2022 Sep.

6 Hoshino E, Konomura K, Obatake M, Moriwaki K, Sakai M, Urayama KY, Shimozuma K. Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups. Pediatr Surg Int. 2022 Apr;38(4):547-554.